Shares of defense and industrial conglomerate Teledyne Technologies sank 1.6 percent in midday trading on Thursday despite higher sales and profits from the Thousand Oaks-based firm.
Thousand Oaks-based Amgen has entered into two new collaborations, one involving treatment for colon cancer and another regarding therapies for inflammatory bowel disease.
Thousand Oaks-based Atara Biotherapeutics has brought on more investors to its second financing round, bringing the total raised to $52 million.
Chief Financial Officer Jonathan M. Peacock is leaving Amgen to pursue broader career opportunities, the company announced. Michael A. Kelly has been named acting CFO.
Ludwig Cancer Research, started by Westlake Village founding developer Daniel K. Ludwig, has donated $540 million to six U.S. Ludwig Centers on behalf of the late philanthropist’s trust, the organization announced Jan. 6.
Strawberries remain the largest piece of the pie in the Tri-Counties’ multibillion-dollar agriculture industry, but there will be slightly less acreage in the New Year.
Thomas Aquinas College in Santa Paula, a Catholic four-year liberal arts college, has prevailed in a lawsuit challenging the birth-control mandate of the Affordable Care Act, the school said Dec. 23.
The U.S. District Court judge, however, ruled against Thomas Aquinas’ co-plaintiffs, including the Catholic University of America and the Roman Catholic Archbishop of Washington, in the suit over the new health-care law.